-
Blenrep fails to receive ODAC support for multiple myeloma use
18 Jul 2025 23:27 GMT
… regimens for certain patients with multiple myeloma.
Committee members voiced concerns over … patients with relapsed/refractory multiple myeloma.
The FDA Oncologic Drugs Advisory … be optimized in coming years. Multiple myeloma is the most common malignancy …
-
FDA Votes Against Proposed Blenrep Treatment Combo’s for Multiple Myeloma
18 Jul 2025 23:19 GMT
… of certain treatments in the multiple myeloma patient population, according to information … patients with relapsed/refractory multiple myeloma who have received at least … previously treated, relapsed/refractory multiple myeloma due to concern that the …
-
FDA Panel Rejects Belantamab Mafodotin Combinations for Multiple Myeloma, Citing Safety Concerns
18 Jul 2025 21:26 GMT
… regimens for relapsed or refractory multiple myeloma (RRMM). The advisory committee … promising combination partner in the multiple myeloma armamentarium with a different … participants with relapsed/refractory multiple myeloma (RRMM) (DREAMM-3). Updated …
-
Healthcare Costs and Treatment Patterns of Triplet Therapies in Relapsed/Refractory Multiple Myeloma: Real World Evidence from Italy
18 Jul 2025 20:16 GMT
… Anti CD38 monoclonal antibodies for multiple myeloma treatment. Hum Vaccin Immunother. … as a prognostic variable in multiple myeloma: comparative evaluation of common … and disease-related complications in multiple myeloma: implications for survivorship. Am …
-
ODAC Votes Against Risk-Benefit Profile of GSK’s Blenrep Combinations in Relapsed/Refractory Multiple Myeloma
18 Jul 2025 19:08 GMT
… approval regulations and associated process. Multiple myeloma is a challenging disease, … combinations-for-patients-with-relapsedrefractory-multiple-myeloma/
FDA Accepts GSK … Blenrep for Relapsed or Refractory Multiple Myeloma. PharmExec. December 2, 2024 …
-
Espanola paramedic Ashley Dieks' uphill battle with multiple myeloma
18 Jul 2025 16:54 GMT
… 2007, was diagnosed with multiple myeloma, cancer of the blood … joined together for a multiple myeloma fundraiser, BBQ, Car … 2007, was diagnosed with multiple myeloma, cancer of the blood … Dieks was diagnosed with multiple myeloma, a life-altering diagnosis …
-
NCCN Flash Update: Linvoseltamab Added as Preferred Regimen After 4 Prior Therapies for Multiple Myeloma
18 Jul 2025 16:14 GMT
… Practice Guidelines in Oncology for multiple myeloma, with corresponding updates to the … . Clinical Practice Guidelines in Oncology. Multiple myeloma, version 2.2026. July 16 …
-
ODAC Votes Against 2 Belantamab Mafodotin Combinations in Multiple Myeloma
17 Jul 2025 23:46 GMT
… Blenrep in relapsed/refractory multiple myeloma. News release. GSK. November … treatment of relapsed/refractory multiple myeloma. News release. GSK. November … dexamethasone in relapsed/refractory multiple myeloma: overall survival analysis and …
-
Prior BCMA-Directed Therapy Linked to Diminished Teclistamab Efficacy in Relapsed/Refractory Multiple Myeloma
17 Jul 2025 21:54 GMT
… patients with relapsed/refractory multiple myeloma (RRMM) treated with teclistamab ( … were participating in the US Multiple Myeloma Immunotherapy Consortium.
The study included … with relapsed/refractory multiple myeloma with prior exposure to BCMA …
-
Behind the RedirecTT-1 Study in Multiple Myeloma With EMD
17 Jul 2025 21:54 GMT
… patients with relapsed/refractory multiple myeloma (RRMM) complicated by extramedullary disease … patients with relapsed/refractory multiple myeloma and extramedullary disease: REDIRECTT-1 …
About
© 1995-2025